212 Drugs in development for RAI-refractory differentiated thyroid cancer. New Molecular Targets
59:12
231 The changing landscape of papillary & follicular thyroid cancer: What do patients need to know?
1:00:36
351 The importance of lifetime follow-up
1:27:28
The Continuing Success Story of Immunotherapy in NSCLC
50:42
352 The risks of secondary cancers from radioactive iodine treatment
52:22
Living long term with MBC: Making treatment decisions
53:59
322 How to be your best advocate for surgery
1:00:43
Update on Management of Medullary Thyroid Cancer w/ Dr. Hu
57:19